Selective retina therapy in patients with diabetic maculopathy [Selektive retina-therapie bei patienten mit diabetischer makulopathie]

被引：0
|
作者：
Elsner H. [1 ,5 ]
Klatt C. [1 ]
Liew S.H.M. [2 ]
Pörksen E. [1 ]
Bunse A. [1 ]
Rudolf M. [1 ]
Brinkmann R. [3 ]
Hamilton R.P. [2 ]
Birngruber R. [3 ]
Laqua H. [4 ]
Roider J. [1 ]
机构：
[1] Klinik für Augenheilkunde, UKSH, Campus Kiel
[2] St. Thomas Hospital, London
[3] Institut für Biomedizinische Optik, Universität Zu Lübeck und Medizinisches Laserzentrum Lübeck GmbH, Lübeck
[4] Klinik für Augenheilkunde, UKSH, Campus Lübeck, Lübeck
[5] Klinik für Augenheilkunde, UKSH, Campus Kiel, 24105 Kiel
来源：
Der Ophthalmologe | 2006年 / 103卷 / 10期
关键词：
Diabetic maculopathy; OCT; Selective Retina Therapy;
D O I：
10.1007/s00347-006-1414-8
中图分类号：
学科分类号：
摘要：
Selective Retina Therapy (SRT) is a new laser treatment that selectively targets the retinal pigmen epithelium (RPE). In this study, we treated 39 patients presenting with nonischemic, focal and focal-diffuse diabetic maculopathy with SRT. In the main. the results indicate that SRT had stabilizing effects on visual acuity, angiographic leakage, lipid exudation, and foveal retinal thickness. SRT is safe and is especially useful for treating pathologies that are located close to the fovea, which cannot be treated with conventional argon laser photocoagulation. © 2006 Springer Medizin Verlag.
引用
收藏
页码：856 / 860
页数：4
相关论文
共 50 条
12345